Loading…

E066 Baseline characteristics of patients initiating ixekizumab, secukinumab or a tumour necrosis factor inhibitor by country in the 24-month Prospective Psoriatic Arthritis Observational Study of Persistence of Treatment - PRO-SPIRIT

Saved in:

Bibliographic Details
Published in:	Rheumatology (Oxford, England) England), 2024-04, Vol.63 (Supplement_1)
Main Authors:	Gullick, Nicola, Sheesh, Mohamed, Laedermann, Cedric, Ngantcha, Marcus, Gittens, Beatrice, Ng, Khai Jing, Tillett, William, Morel, Jacques, Lubrano, Ennio, Alten, Rieke, Kristensen, Lars Erik, Chandran, Vinod, Martinez-Ferrer, Angels, Kirkham, Bruce
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!